Asset Details
Do you wish to reserve the book?
Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of Aflibercept
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of Aflibercept
Do you wish to request the book?
Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of Aflibercept
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Reduction of Diabetic Macular Edema in the Untreated Fellow Eye Following Intravitreal Injection of Aflibercept
2016
Overview
A 59-year-old patient with bilateral worsening diabetic macular edema received intravitreal injection of aflibercept (Eylea; Regeneron, Tarrytown, NY) to the left eye only. On 1-month follow-up, there was noted bilateral improvement of visual acuity and diabetic macular edema on spectral-domain optical coherence tomography imaging, reflecting bilateral effect of unilateral treatment with aflibercept. [ Ophthalmic Surg Lasers Imaging Retina. 2016;47:474–476.]
Publisher
SLACK INCORPORATED
Subject
/ Diabetic Retinopathy - complications
/ Diabetic Retinopathy - diagnosis
/ Diabetic Retinopathy - drug therapy
/ Female
/ Humans
/ Intraocular Pressure - drug effects
/ Macular Edema - drug therapy
/ Receptors, Vascular Endothelial Growth Factor - administration & dosage
/ Recombinant Fusion Proteins - administration & dosage
